Arylacetamide Deacetylase-Like 1 (AADACL1) Antibody

Este producto es parte de AADACL - Arylacetamide deacetylase like
Product Graph
637€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Arylacetamide Deacetylase-Like 1 (AADACL1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx111076
tested applications
ELISA, WB

Description

Arylacetamide Deacetylase-Like 1 Antibody is a Rabbit Polyclonal antibody against Arylacetamide Deacetylase-Like 1.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Arylacetamide Deacetylase-Like 1 (AADACL1)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Antigen Affinity Chromatography.
Size 1
100 µl
Form
Liquid
Tested Applications
ELISA, WB
Buffer
PBS, pH 7.3, containing 0.1% Sodium Azide and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q6PIU2
Gene ID
57552
NCBI Accession
NP_001139748.1
OMIM
613234
Alias
NCEH1,AADACL1,NCEH, Arylacetamide deacetylase like 1
Background
Antibody anti-NCEH1
Status
RUO

Descripción

Neutral cholesterol ester hydrolase 1 (NCEH1) is an enzyme involved in the hydrolysis of cholesterol esters into free cholesterol and fatty acids, playing a critical role in cholesterol metabolism and homeostasis. It is primarily localized in the cytosol and is highly expressed in tissues such as the liver, macrophages, and adrenal glands, where cholesterol metabolism is vital. NCEH1 contributes to the regulation of intracellular cholesterol levels and is involved in processes such as lipid droplet mobilization and reverse cholesterol transport. It also plays a significant role in foam cell formation in atherosclerotic plaques, highlighting its involvement in cardiovascular disease. Dysregulation or mutations in NCEH1 have been linked to lipid metabolism disorders and increased susceptibility to atherosclerosis, making it a potential therapeutic target for modulating cholesterol homeostasis and reducing cardiovascular risk.

Related Products

FNab00017

anti- AADACL1 antibody

AADACL1(Arylacetamide deacetylase-like 1) is also named as NCEH1, KIAA1363 and belongs to the 'GDXG' lipolytic enzyme family. The transmembrane enzyme, AADACL1, controls the production of the monoalkylglycerol ether(MAGE) class of NELs in cancer cells and acts as a 2-acetyl MAGE hydrolase and is likely the principal source for this activity in tumor cells(PMID:21513884). The full length protein has three glycosylation sites and can be N-glycosylated(PMID:19159218). It has 3 isoforms produced by alternative splicing.

Ver Producto
abx111076

Arylacetamide Deacetylase-Like 1 (AADACL1) Antibody

Arylacetamide Deacetylase-Like 1 Antibody is a Rabbit Polyclonal antibody against Arylacetamide Deacetylase-Like 1.

Ver Producto
abx214983

Neutral cholesterol ester hydrolase 1 (NCEH1) Antibody

NCEH1 Antibody is a Rabbit Polyclonal against NCEH1.

Ver Producto